High Mobility Group 20B (HMG20B) Peptide
HMG20B
Reactivity: Human
Host: Synthetic
BP
Catalog No. ABIN2711692
Quick Overview for High Mobility Group 20B (HMG20B) Peptide (ABIN2711692)
Target
HMG20B
(High Mobility Group 20B (HMG20B))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP)
-
-
Characteristics
- The peptide is used to block Anti-BRAF35 Antibody reactivity.
-
-
-
-
Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Storage
- -20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
-
Expiry Date
- 12 months
-
-
- HMG20B (High Mobility Group 20B (HMG20B))
-
Background
- BRAF35, HMGX2, HMGXB2, SMARCE1R, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related, SMARCE1-related protein, BRCA2-associated factor 35, HMG box-containing protein 20B, HMG domain-containing protein 2, HMG domain-containing protein HMGX2, Sox-like transcriptional factor, Structural DNA-binding protein BRAF35
-
Gene ID
- 10362
-
UniProt
- Q9P0W2
Target
-
You are here:
